Evidence map›Paper›PMID 29285660›Full record

ArticleCellular and molecular neurobiology2018

Effect of Blood Phenylalanine Levels on Oxidative Stress in Classical Phenylketonuric Patients.

Burcu Kumru, Davut Sinan Kaplan, Burcu Oztürk Hismi, Hakim Celik

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Antioxidants (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Impact of pregnancy on inborn errors of metabolism.Reviews in endocrine & metabolic disorders · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Burcu KumruDivision of Nutrition and Diet, Gaziantep Cengiz Gökçek Maternity and Children's Hospital, Gaziantep, Turkey. burcu-kumru@hotmail.com.
Davut Sinan KaplanDivision of Physiology, Gaziantep University, Gaziantep, Turkey.
Burcu Oztürk HismiDivision of Pediatric Metabolism and Nutrition, Tepecik Training and Research Hospital, Izmir, Turkey.
Hakim CelikDivision of Physiology, Harran University, Sanlıurfa, Turkey.
Gaziantep Children's Hospital · TRGaziantep University · TRHarran University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mental retardation, which occurs in phenylketonuric patients, is associated with increased levels of phenylalanine, increased oxidative stress, and an imbalance of amino acids in the brain. Recent studies have shown that oxidative stress plays a role in the pathogenesis of phenylketonuria. In this work, we aimed to compare the influence of blood phenylalanine levels on oxidative stress parameters in phenylketonuric patients who divided patients into groups according to blood Phe levels during follow-up visits and compared these groups with healthy controls. Results showed significant differences in glutathione peroxidase (GSHPx), coenzyme Q10 (Q10), Q10/cholesterol, and L-carnitine levels in phenylketonuria patients and the control group. GSHPx, Q10, and Q10/cholesterol levels were significantly lower in poor adherence patients than in the control groups. L-carnitine levels were significantly increased in good adherence patients than poor adherence patients and decreased in poor adherence patients than healthy controls. No correlations were observed between phenylalanine and L-carnitine concentrations in poor adherence group. No significant differences were observed in paraoxonase 1 (PON1), total antioxidant status (TAS), total oxidant status (TOS) and oxidative stress index (OSI) levels. As a result, in this work, poor adherence patients are prone to oxidative stress. Although the patients may have the same diagnosis, patients have different clinical characteristics and different prognosis. Antioxidants can be used as an adjuvant therapy in order to avoid neurological damage in these patients.

Indexed as

Oxidative StressCase-Control StudiesFemaleHumansPhenylalaninePhenylketonuriasPregnancyPhenylalanineAntioxidantNeuroprotectionOxidative stressPhenylketonuria

Identifiers

PMID29285660
PMCPMC11481976
OpenAlexW2781203447

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.